GraphIX: Graph-based In silico XAI(explainable artificial intelligence) for drug repositioning from biopharmaceutical network

• URL: http://arxiv.org/abs/2212.10788v1
• Date: Wed, 21 Dec 2022 06:17:45 GMT
• Title: GraphIX: Graph-based In silico XAI(explainable artificial intelligence) for drug repositioning from biopharmaceutical network
• Authors: Atsuko Takagi, Mayumi Kamada, Eri Hamatani, Ryosuke Kojima, Yasushi Okuno
• Abstract summary: GraphIX is an explainable drug repositioning framework using biological networks. It can present to users new disease-drug associations and identify the protein important for understanding its pharmacological effects.
• Score: 1.4174475093445233
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: Drug repositioning holds great promise because it can reduce the time and cost of new drug development. While drug repositioning can omit various R&D processes, confirming pharmacological effects on biomolecules is essential for application to new diseases. Biomedical explainability in a drug repositioning model can support appropriate insights in subsequent in-depth studies. However, the validity of the XAI methodology is still under debate, and the effectiveness of XAI in drug repositioning prediction applications remains unclear. In this study, we propose GraphIX, an explainable drug repositioning framework using biological networks, and quantitatively evaluate its explainability. GraphIX first learns the network weights and node features using a graph neural network from known drug indication and knowledge graph that consists of three types of nodes (but not given node type information): disease, drug, and protein. Analysis of the post-learning features showed that node types that were not known to the model beforehand are distinguished through the learning process based on the graph structure. From the learned weights and features, GraphIX then predicts the disease-drug association and calculates the contribution values of the nodes located in the neighborhood of the predicted disease and drug. We hypothesized that the neighboring protein node to which the model gave a high contribution is important in understanding the actual pharmacological effects. Quantitative evaluation of the validity of protein nodes' contribution using a real-world database showed that the high contribution proteins shown by GraphIX are reasonable as a mechanism of drug action. GraphIX is a framework for evidence-based drug discovery that can present to users new disease-drug associations and identify the protein important for understanding its pharmacological effects from a large and complex knowledge base.

Related papers

• Emerging Drug Interaction Prediction Enabled by Flow-based Graph Neural Network with Biomedical Network [69.16939798838159]
  We propose EmerGNN, a graph neural network (GNN) that can effectively predict interactions for emerging drugs. EmerGNN learns pairwise representations of drugs by extracting the paths between drug pairs, propagating information from one drug to the other, and incorporating the relevant biomedical concepts on the paths. Overall, EmerGNN has higher accuracy than existing approaches in predicting interactions for emerging drugs and can identify the most relevant information on the biomedical network.
  arXiv  Detail & Related papers  (2023-11-15T06:34:00Z)
• A Comparative Study of Population-Graph Construction Methods and Graph Neural Networks for Brain Age Regression [48.97251676778599]
  In medical imaging, population graphs have demonstrated promising results, mostly for classification tasks. extracting population graphs is a non-trivial task and can significantly impact the performance of Graph Neural Networks (GNNs) In this work, we highlight the importance of a meaningful graph construction and experiment with different population-graph construction methods.
  arXiv  Detail & Related papers  (2023-09-26T10:30:45Z)
• GraphCL-DTA: a graph contrastive learning with molecular semantics for drug-target binding affinity prediction [2.523552067304274]
  GraphCL-DTA is a graph contrastive learning framework for molecular graphs to learn drug representations. Next, we design a new loss function that can be directly used to adjust the uniformity of drug and target representations. The effectiveness of the above innovative elements is verified on two real datasets.
  arXiv  Detail & Related papers  (2023-07-18T06:01:37Z)
• Dynamic Graph Enhanced Contrastive Learning for Chest X-ray Report Generation [92.73584302508907]
  We propose a knowledge graph with Dynamic structure and nodes to facilitate medical report generation with Contrastive Learning. In detail, the fundamental structure of our graph is pre-constructed from general knowledge. Each image feature is integrated with its very own updated graph before being fed into the decoder module for report generation.
  arXiv  Detail & Related papers  (2023-03-18T03:53:43Z)
• Drug Synergistic Combinations Predictions via Large-Scale Pre-Training and Graph Structure Learning [82.93806087715507]
  Drug combination therapy is a well-established strategy for disease treatment with better effectiveness and less safety degradation. Deep learning models have emerged as an efficient way to discover synergistic combinations. Our framework achieves state-of-the-art results in comparison with other deep learning-based methods.
  arXiv  Detail & Related papers  (2023-01-14T15:07:43Z)
• Analysis of Drug repurposing Knowledge graphs for Covid-19 [0.0]
  This study proposes a set of candidate drugs for COVID-19 using Drug repurposing knowledge graph (DRKG) DRKG is a biological knowledge graph constructed using a vast amount of open source biomedical knowledge. nodes and relation embeddings are learned using knowledge graph embedding models and neural network and attention related models.
  arXiv  Detail & Related papers  (2022-12-07T19:14:17Z)
• A Deep Learning Approach to the Prediction of Drug Side-Effects on Molecular Graphs [2.4087148947930634]
  We develop a methodology to predict drug side-effects using Graph Neural Networks. We build a dataset from freely accessible and well established data sources. The results show that our method has an improved classification capability, under many parameters and metrics.
  arXiv  Detail & Related papers  (2022-11-30T10:12:41Z)
• Contrastive Brain Network Learning via Hierarchical Signed Graph Pooling Model [64.29487107585665]
  Graph representation learning techniques on brain functional networks can facilitate the discovery of novel biomarkers for clinical phenotypes and neurodegenerative diseases. Here, we propose an interpretable hierarchical signed graph representation learning model to extract graph-level representations from brain functional networks. In order to further improve the model performance, we also propose a new strategy to augment functional brain network data for contrastive learning.
  arXiv  Detail & Related papers  (2022-07-14T20:03:52Z)
• Graph-in-Graph (GiG): Learning interpretable latent graphs in non-Euclidean domain for biological and healthcare applications [52.65389473899139]
  Graphs are a powerful tool for representing and analyzing unstructured, non-Euclidean data ubiquitous in the healthcare domain. Recent works have shown that considering relationships between input data samples have a positive regularizing effect for the downstream task. We propose Graph-in-Graph (GiG), a neural network architecture for protein classification and brain imaging applications.
  arXiv  Detail & Related papers  (2022-04-01T10:01:37Z)
• Relational graph convolutional networks for predicting blood-brain barrier penetration of drug molecules [12.041672273431994]
  The evaluation of the BBB penetrating ability of drug molecules is a critical step in brain drug development. We employ the relational graph convolutional network (RGCN) to handle the drug-protein relations as well as the features of each individual drug. The performance was already promising, demonstrating the significant role of the drug-protein/drug relations in the prediction of BBB permeability.
  arXiv  Detail & Related papers  (2021-07-04T15:56:02Z)
• A Review of Biomedical Datasets Relating to Drug Discovery: A Knowledge Graph Perspective [4.746544835197422]
  We aim to help guide machine learning and knowledge graph practitioners who are interested in applying new techniques to the drug discovery field. We detail publicly available primary data sources containing information suitable for use in constructing various drug discovery focused knowledge graphs.
  arXiv  Detail & Related papers  (2021-02-19T17:49:38Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.